ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Michael J. Sofia, Chief Scientific Officer at Arbutus Biopharma, will share the 2016 Lasker-DeBakey Clinical Medical Research Award with Ralf F.W. Bartenschlager of the University of Heidelberg and Charles M. Rice of Rockefeller University. The scientists are being honored for their development of a system to study the replication of the virus that causes hepatitis C and for using the system to revolutionize the treatment of the disease.
The Lasker Awards honor accomplishments in basic and clinical medical research and special achievement. The awards carry an honorarium of $250,000 for each category and are shared equally among the recipients of each award. Many Lasker laureates have gone on to win the Nobel Prize.
“When one gets the opportunity to meet patients whose lives have been transformed by a drug that you have helped create and hear their stories of life-long struggle and ultimate triumph, that provides motivation enough to want to keep on trying to make a difference,” says Sofia, who discovered the compound sofosbuvir, which led to the hepatitis C virus drug, Sovaldi. “It should be noted that the discovery and development of a drug like sofosbuvir cannot be done by one individual. It takes the hard work of many individuals to take an idea and make it a reality for patients. I am honored and humbled to be able to represent all of those dedicated scientists who have been part of this incredible success story.”
In addition, William G. Kaelin, Peter J. Ratcliffe, and Gregg L. Semenza were awarded the 2016 Albert Lasker Basic Medical Research Award for the discovery of the pathway by which cells from humans and most animals sense and adapt to changes in oxygen availability, a process essential for survival.
And Bruce M. Alberts is the recipient of the 2016 Lasker-Koshland Special Achievement Award in Medical Science for fundamental discoveries in DNA replication and protein biochemistry, for visionary leadership in directing national and international scientific organizations to better people’s lives, and for passionate dedication to improving education in science and mathematics.
“The 2016 Lasker winners combined exceptional insight, creativity, and perseverance in pursuing crucial questions in medical science,” said Joseph L. Goldstein, chair of the Lasker Medical Research Awards jury. The award will be presented on Friday, Sept. 23, in New York City.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X